In modern pharmaceutical research and organic synthesis, fused heterocyclic compounds have become indispensable structural motifs for drug design. Among these, imidazo[1,2-a]pyrazine derivatives have gained significant attention due to their rigid fused-ring system, high biological relevance, and excellent functionalization potential.
One such compound is 6-Bromoimidazo[1,2-a]pyrazine (CAS 912773-24-1), a brominated fused heterocycle widely used as an intermediate in medicinal chemistry, drug discovery, and advanced organic synthesis.
Although it is not an active pharmaceutical ingredient itself, its importance lies in its role as a versatile building block that enables chemists to construct structurally complex and biologically active molecules efficiently.
This article provides a comprehensive overview of its chemical identity, structural features, synthesis applications, pharmaceutical relevance, handling requirements, and industrial significance.
6-Bromoimidazo[1,2-a]pyrazine is a halogenated fused heterocyclic compound composed of an imidazole ring fused with a pyrazine system, further substituted with a bromine atom.
Chemical Name: 6-Bromoimidazo[1,2-a]pyrazine
CAS Number: 912773-24-1
Molecular Formula: C₆H₄BrN₃
Molecular Weight: 198.02 g/mol
Chemical Class: Fused heterocyclic brominated compound
Core Structure: Imidazo[1,2-a]pyrazine scaffold
The molecule is built on a rigid bicyclic nitrogen-rich framework, which is highly valued in medicinal chemistry due to its ability to mimic biologically active heterocycles and interact strongly with protein binding sites.
The structure of 6-Bromoimidazo[1,2-a]pyrazine defines its chemical behavior and pharmaceutical relevance. It combines three essential features that contribute to its versatility:
The central scaffold consists of a fused bicyclic system combining imidazole and pyrazine rings. This structure is:
Aromatic and highly stable
Electron-deficient due to multiple nitrogen atoms
Rigid in conformation, enhancing binding specificity
Such fused heterocycles are frequently found in bioactive compounds, especially kinase inhibitors and enzyme modulators.
The bromine atom is one of the most important functional features of this molecule.
It provides:
A highly reactive leaving group for substitution reactions
A handle for cross-coupling chemistry (Suzuki, Buchwald-type reactions)
A site for introducing diverse substituents into the heterocyclic framework
This makes the compound extremely valuable for diversity-oriented synthesis and medicinal chemistry optimization.
The presence of multiple nitrogen atoms in the fused ring system contributes to:
Hydrogen bonding capability
Increased polarity and binding interactions
Enhanced biological recognition potential
Improved interaction with enzyme active sites
These properties make imidazo[1,2-a]pyrazine derivatives particularly attractive in drug discovery programs.
Understanding the physical characteristics of 6-Bromoimidazo[1,2-a]pyrazine is essential for laboratory handling and application.
Typical properties include:
Appearance: White to yellow or yellow-brown crystalline solid
Molecular weight: 198.02 g/mol
Stability: Stable under dry and dark storage conditions
Solubility: Limited solubility in water, soluble in organic solvents such as DMSO or DMF
Storage conditions: 2–8°C recommended or cool, dry environment
Purity: Typically ≥97% (research grade)
These properties make it suitable for controlled synthetic chemistry and pharmaceutical research applications.
One of the most important applications of 6-Bromoimidazo[1,2-a]pyrazine is its use as a reactive intermediate in organic synthesis.
The bromine substituent enables a wide range of cross-coupling reactions, including:
Suzuki–Miyaura coupling
Buchwald–Hartwig amination
Heck-type coupling reactions
These reactions allow chemists to introduce a variety of functional groups, significantly expanding molecular diversity.
The compound serves as a starting point for building more complex heterocyclic systems. Through selective transformations, chemists can:
Replace bromine with aryl or alkyl groups
Introduce nitrogen, oxygen, or sulfur substituents
Construct multi-ring fused heterocycles
This flexibility is essential in modern synthetic design strategies.
The rigid fused structure makes it ideal for scaffold-based synthesis approaches, where the core structure is retained while peripheral modifications are introduced.
This is particularly useful in:
Lead optimization
Structure–activity relationship studies
Chemical library expansion
Fused heterocyclic systems like imidazo[1,2-a]pyrazine are widely studied in pharmaceutical research due to their strong biological relevance.
6-Bromoimidazo[1,2-a]pyrazine plays a key role in:
It serves as a core scaffold or intermediate in the development of:
Kinase inhibitors
Anticancer agents
Antimicrobial compounds
Anti-inflammatory drug candidates
The rigid fused structure enhances binding affinity and selectivity toward biological targets.
In SAR studies, this compound is used to systematically modify molecular structures to understand how changes affect biological activity.
Researchers analyze:
Substituent effects on potency
Electronic distribution changes
Binding interactions with receptors
Pharmacokinetic properties
Due to its compact and rigid structure, 6-Bromoimidazo[1,2-a]pyrazine can also be used as a fragment-like scaffold in early-stage drug discovery.
Fragment-based approaches rely on small, efficient molecules that can be chemically expanded into more potent compounds.
Modern drug discovery heavily relies on compound libraries for high-throughput screening.
This compound is widely used in:
Heterocyclic screening libraries
Diversity-oriented synthesis (DOS) collections
Fragment-based chemical libraries
Lead identification platforms
Its bromine functionality allows rapid derivatization, making it ideal for generating structurally diverse compound sets.
Proper handling ensures both safety and chemical integrity.
Recommended guidelines include:
Store in tightly sealed containers
Keep in cool, dry, and dark environments
Maintain at 2–8°C if possible
Avoid exposure to moisture and air
Use appropriate PPE (gloves, goggles, lab coat)
Work under ventilated laboratory conditions
These precautions ensure long-term stability and reproducibility in research.
As with most halogenated heterocyclic compounds:
For laboratory research use only
Not intended for human or veterinary use
Avoid inhalation, ingestion, or skin contact
Always consult the Safety Data Sheet (SDS) before use
Handle according to standard chemical safety protocols
While not highly hazardous under normal conditions, it must still be treated as a laboratory chemical with appropriate caution.
Although not a bulk industrial chemical, 6-Bromoimidazo[1,2-a]pyrazine plays an important role in:
Pharmaceutical R&D pipelines
Medicinal chemistry optimization
Fine chemical synthesis
Custom compound development projects
Its primary value lies in its ability to serve as a structural platform for biologically active molecules.
The demand for fused heterocyclic intermediates such as imidazo[1,2-a]pyrazine derivatives continues to rise due to:
Growth in kinase-targeted drug discovery
Expansion of heterocyclic chemical space exploration
Increased use of high-throughput screening technologies
Rising demand for brominated cross-coupling substrates
Chemists prefer compounds like this because they offer:
Structural rigidity
High functionalization potential
Strong biological relevance
Synthetic flexibility
6-Bromoimidazo[1,2-a]pyrazine (CAS 912773-24-1) is a highly valuable fused heterocyclic intermediate widely used in organic synthesis and medicinal chemistry.
Its imidazo[1,2-a]pyrazine scaffold combined with a reactive bromine substituent makes it an ideal building block for cross-coupling reactions, molecular diversification, and drug discovery applications.
While it is not a final pharmaceutical compound, it plays a crucial role in enabling the synthesis of more complex and biologically relevant molecules. As medicinal chemistry continues to evolve, compounds like this remain essential tools in the discovery of future therapeutic agents.
| Cas | Product name | Quantity (g/kg/mt) | Notes |
|---|---|---|---|
Inquiry Now
We’re thrilled to receive your inquiry!
Simply fill out the form below, and rest assured, we’ll respond to you promptly.
